Edwards MH, Dennison EM, Aihie SA, Fielding R, Cooper C
Doctors commonly prescribe it for neuropathy, especially in diabetic patients who experience tingling, numbness, or burning sensations
"I think the main issue is a lack of regulation by the FDA," Mullally said
These agents mimic the biological action of the native incretin hormone GLP-1 but are structurally modified to resist degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), thereby extending their half-life and duration of action (Zheng et al., 2024
It has been observed to influence signaling molecules such as TGF- and VEGF at the molecular level
Third, measurement errors in self-reported dietary behaviors were inevitable